Technology

Cosmederm Bioscience has a family of patented anti-itch, anti-inflammatory and anti-irritant compounds that have been developed for dermatological applications and are being investigated for use in other areas including gastrointestinal disease, respiratory disease and conditions affecting the mucous membranes. The efficacy of our technology has been proven in well-controlled human clinical trials, published in peer-reviewed medical journals and textbooks. These clinical trials demonstrate that our compounds, when topically-applied, can selectively suppress the symptoms of sensory irritation (stinging, burning and itching) without affecting other cutaneous sensations. Of particular relevance to the treatment of inflammatory dermatoses, these studies demonstrate suppression of itch and inflammation caused by a variety of chemical irritants, including histamine, as well as itch triggered by an IgE-mediated allergic response (Type I hypersensitivity) which contributes to the pathogenesis and itching of atopic dermatitis and other itch-associated conditions.